Literature DB >> 26089264

[Sclerosing acral skin perineurioma: clinicopathologic study of ten cases (eight classical and two with xanthomatous changes)].

Sonia Toussaint-Caire1, Adriana Aguilar-Donis2, Edoardo Torres-Guerrero2, Daniel Asz-Sigall2, María Elisa Vega-Memije1, Rosa María Lacy-Niebla2, Judith Domínguez-Cherit2, Patricia Alfaro Ledesma2, Carlos Ortiz-Hidalgo3.   

Abstract

INTRODUCTION: Perineurioma is an infrequent and benign cutaneous neoplasm characterized by proliferation of perineurial cells. It is classified into two main types: intraneural and the extraneural or soft tissue perineurioma, in which the sclerosing variant is included. Sclerosing perineurioma is more frequently found on acral skin. Clinically, they are well-circumscribed,skin colored, nodular tumors.
OBJECTIVE: Describe and communicate clinicopathologic findings from a case series of sclerosing acral perineurioma.
MATERIAL AND METHODS: This is a clinical, morphological and immunohistologic case study of eight patients with the diagnosis of sclerosing perineurioma.
RESULTS: It included five men and five women, with ages ranging between nine and 66 years. All of them had lesion on acral skin. At microscopy study, the lesions showed a proliferation of epithelioid and spindle-shaped perineurial cells, arranged in small aggregates and short fascicles between thickened collagen bundles. Immunohistochemistry studies revealed that the proliferating cells expressed EMA, Claudin-1 and Glut-1, and were negative for S-100 protein.
CONCLUSIONS: It is important to report these infrequent skin tumors, so they can be taken into account in the differential diagnoses of acral lesions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26089264

Source DB:  PubMed          Journal:  Gac Med Mex        ISSN: 0016-3813            Impact factor:   0.302


  1 in total

1.  Left Supraclavicular Swelling: Sclerosing Perineurioma.

Authors:  Antonio Tancredi; Paolo Graziano; Lucia Dimitri; Elvira Impagnatiello; Marco Taurchini
Journal:  Eurasian J Med       Date:  2018-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.